Company Overview
VIKING THERAPEUTICS, INC.
VKTXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
0M
2025 FY
Net Income
-360M
2025 FY
Shares Outstanding
113M
2025 FY
EPS
-3.19USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1607678
Exchange
Nasdaq
Location
US